Under the Aegis of Global Oncology Forum a CME on Latest Updates on Management of HER2 Low/Positive Metastatic Breast Cancer was organized by the Deptt. of Medical Oncology

Director, Dr. RMLIMS Prof. (Dr.)C.M.Singh was the Chief Guest of the program.  The CME was witnessed by Prof. P.K.Das, Acting Dean,  faculty delegates and Residents, maximum attendance was  from the department of cardiothoracic and vascular surgery, along with the HOD Prof (Dr) A P Jain. . The guest speakers Dr.Alok Gupta, Director Medical Oncology, Medanta Hospital, Dr. Vikas Tareja, Press 

Director Medical Oncology, Regency Kanpur, Dr. Gaurav Gupta, Ex-HOD, Deptt. of Medical Oncology, Dr.RMLIMS & Dr. Satya Sarangi, Faculty, SGPGIMS delivered the talk  on various topics i.e. Evolving paradigm of HER2 Testing in Breast Cancer: Clinical Implications and Pathology, ADCs in HER2-e and HER2 Classification ,Clinical Perspective on CDK4/6 inhibitors in HR+ve HER2-ve , Case Based Panel Discussion on HER2 positive metastatic breast cancer. 

The program was coordinated by Prof.Rohini Khurana, Deptt. of Radiation Oncology & Organizing Chairperson of the CME and Dr. Saksham Singh, Assistant Faculty, Deptt. of Medical Oncology  & Organizing Secretary of the CME.
Dr.Gaurav Gupta,
Medical oncologist, director optimus has said light on your developments of HER2 Testing.
Dr Satya Sarangi faculty SGPGI discussed about targeted therapy  of hormone positive breast cancer.
Dr Alok Gupta leading medical oncologist from medanta moderated panel on clinical scenario of the breast cancer. 
Dr Vikas Talreja leading practitioner from regency Kanpur has set light on pathological aspects of breast cancer. 
Director Prof. CM Singh emphasized on the burden of the breast cancer in the population, it's early diagnosis by screening.
The academic symposium  was compered by Mrs. Nimisha Sonker. Media PR Cell was also present during the program.